Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

Presentation NY Valves 2024

Percutaneous PVR II: What Technologies Are Coming, and How Will They Change Things?

Presenter: Barry A. Love

June 07, 2024

Presentation THT 2023

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Presenter: NULL

March 22, 2023

Presentation TVT 2022

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Presenter: Sanjiv Shah

June 10, 2022

Presentation CACI 2019

Transcatheter pulmonary valve replacement: how to select patients & valves?

Presenter: Alejandro Peirone

November 29, 2019

Presentation TCT 2019

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Presenter: Chiu Wong

September 27, 2019

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

Presentation TCT 2016

Complications of Transcatheter PVR

Presenter: John P. Cheatham, Matthew J. Gillespie, Thomas K. Jones

November 01, 2016

Presentation TCT 2016

Transcatheter PVR for Native Outflow Tracts: How Much Can We Do With the Currently Approved Valves (Including Hybrid)?

Presenter: John P. Cheatham, Matthew J. Gillespie, Evan Zahn

November 01, 2016

Presentation TCT 2016

Transcatheter PVR Using the Edwards and Melody Valves in Patients With Conduits and Bioprosthetic Valves: Technical Considerations

Presenter: John P. Cheatham, Matthew J. Gillespie, Jacqueline Kreutzer

November 01, 2016

Presentation TCT 2016

Assessment of PR Severity, and Review of the Guidelines for Transcatheter PVR

Presenter: John P. Cheatham, Matthew J. Gillespie

November 01, 2016

Presentation TVT 2016

State-of-the-Art Approach to Reducing Conduction Abnormalities and PVR During TAVR

Presenter: Bernard Prendergast

June 16, 2016

Presentation TVT 2016

Imaging Preferences and Hemodynamic Assessments to Determine the Severity of PVR During TAVR: Factors Influencing Treatment Thresholds

Presenter: Didier Tchetche

June 16, 2016

Presentation TVT 2016

Echo and CT Patterns of Calcification and Annulus Geometry Can Usually Predict PVR During TAVR

Presenter: Omar K. Khalique

June 16, 2016

Presentation TVT 2016

Achieving the Intended Implant Depth During TAVR: Obstacles and Solutions

Presenter: Nicolo Piazza

June 16, 2016

Presentation TVT 2016

Can CT Imaging Help to Characterize High-Risk Patients for Conduction Disturbances During TAVR?

Presenter: Jonathon A. Leipsic

June 16, 2016

Presentation TVT 2016

State-of-the-Art Approach to TAVR in Bicuspid Aortic Valve Disease: From Patient Screening to Device Selection and Procedural Techniques

Presenter: Horst Sievert

June 16, 2016

Presentation TVT 2016

TAVR Valve Sizing and Positioning for Bicuspid Aortic Valve Disease: Is Undersized and Supraannular Best?

Presenter: Nicolo Piazza

June 16, 2016

Presentation TVT 2016

A New CT-Based Diagnostic Schema for Classifying Bicuspid Aortic Valve Disease: Implications for TAVR Treatment

Presenter: Hasan Jilaihawi

June 16, 2016

Presentation TVT 2016

Epidemiology of Bicuspid Aortic Valve Disease in Younger Patients

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TCT 2015

TCT 32: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in Patients With Ischemic Dilated Heart Failure Two-Year Results of the PARACHUTE III European Postmarket Trial

Presenter: John P. Cheatham, Carlos Pedra, Ulrich Schaefer

October 13, 2015

Advertisement

Percutaneous PVR II: What Technologies Are Coming, and How Will They Change Things?

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Transcatheter pulmonary valve replacement: how to select patients & valves?

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

Complications of Transcatheter PVR

Transcatheter PVR for Native Outflow Tracts: How Much Can We Do With the Currently Approved Valves (Including Hybrid)?

Transcatheter PVR Using the Edwards and Melody Valves in Patients With Conduits and Bioprosthetic Valves: Technical Considerations

Assessment of PR Severity, and Review of the Guidelines for Transcatheter PVR

State-of-the-Art Approach to Reducing Conduction Abnormalities and PVR During TAVR

Imaging Preferences and Hemodynamic Assessments to Determine the Severity of PVR During TAVR: Factors Influencing Treatment Thresholds

Echo and CT Patterns of Calcification and Annulus Geometry Can Usually Predict PVR During TAVR

Achieving the Intended Implant Depth During TAVR: Obstacles and Solutions

Can CT Imaging Help to Characterize High-Risk Patients for Conduction Disturbances During TAVR?

State-of-the-Art Approach to TAVR in Bicuspid Aortic Valve Disease: From Patient Screening to Device Selection and Procedural Techniques

TAVR Valve Sizing and Positioning for Bicuspid Aortic Valve Disease: Is Undersized and Supraannular Best?

A New CT-Based Diagnostic Schema for Classifying Bicuspid Aortic Valve Disease: Implications for TAVR Treatment

Epidemiology of Bicuspid Aortic Valve Disease in Younger Patients

TCT 32: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in Patients With Ischemic Dilated Heart Failure Two-Year Results of the PARACHUTE III European Postmarket Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content